Core Viewpoint - Tianyu Co., Ltd. has received the European Pharmacopoeia Certificate of Suitability (CEP) for the active pharmaceutical ingredient Brivaracetam, which is used as an adjunctive treatment for partial seizures, particularly in patients who do not respond adequately to other antiepileptic drugs [1] Group 1 - Tianyu Co., Ltd. announced the receipt of the CEP certificate from the European Medicines Agency on August 1 [1] - Brivaracetam is specifically indicated for the adjunctive treatment of partial seizures [1] - The certification highlights the company's commitment to meeting European quality standards for its pharmaceutical products [1]

Group 1 - The company Tianyu Co., Ltd. (300702.SZ) has received the Certificate of Suitability for European Pharmacopoeia (CEP) issued by the European Medicines Agency for the active pharmaceutical ingredient Brivaracetam [1] - Brivaracetam is indicated for the adjunctive treatment of partial-onset seizures, particularly in patients who have inadequate response to other antiepileptic drugs [1]

证券代码：300702 证券简称：天宇股份 公告编号：2025-047 浙江天宇药业股份有限公司 关于公司原料药获得 CEP 证书的公告 生产地址：浙江省台州市临海市头门港经济开发区东海第五大道 15 号 证书编号：CEP 2025-089 - Rev 00 发证机构：欧洲药品质量管理局 本公司董事会及全体董事保证本公告内容不存在虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 浙江天宇药业股份有限公司（以下简称"公司"）收到欧洲药品质量管理局 （以下简称"EDQM"）签发的关于布立西坦原料药的欧洲药典适用性认证证书 （以下简称"CEP 证书"），现将相关情况公告如下： 一、药品基本情况 药品名称：布立西坦 药品生产商/持有人：浙江天宇药业股份有限公司 化、汇率波动等因素影响，敬请广大投资者理性投资，注意防范投资风险。 特此公告。 浙江天宇药业股份有限公司董事会 二〇二五年八月二日 批准日期：2025 年 7 月 31 日 二、药品的其他相关情况 布立西坦适用于部分性癫痫发作的辅助治疗，尤其是对其他抗癫痫药物疗效 不足的患者。 公司于 2025 年 2 月向 EDQM ...

天宇股份(300702.SZ)公告称，公司收到欧洲药品质量管理局签发的布立西坦原料药的欧洲药典适用性 认证证书。该证书的获得表明该原料药符合欧洲药典的质量要求，可以在欧洲市场及承认CEP证书的其 他规范市场进行销售，为公司进一步丰富产品及拓展国际市场带来积极影响。 ...

| 交易日期 | 证券代码 | 证券简称 | 成交价格 | 成交量 | 成交金额 | 买方营业部 | 卖方营业部 | | --- | --- | --- | --- | --- | --- | --- | --- | | | | | (元) | (万股/万份) | (万元) | | | | 2025-07-31 | 300702 | 天宇股份 | 25.73 | 50.00 | | 1,286.50 中信证券股份有限 | 浙商证券股份有限 | | | | | | | | 公司北京呼家楼证 | 公司台州环城东路 | | | | | | | | 券营业部 | 证券营业部 | 7月31日，天宇股份大宗交易成交50万股，成交额1286.5万元，占当日总成交额的7.69%，成交价25.73元，较市场收盘价 26.25元折价1.98%。 ...

证券代码：300702 证券简称：天宇股份 公告编号：2025-046 浙江天宇药业股份有限公司 关于全资子公司原料药获得 CEP 证书的公告 本公司董事会及全体董事保证本公告内容不存在虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 浙江天宇药业股份有限公司（以下简称"公司"）全资子公司浙江京圣药业 有限公司（以下简称"京圣药业"）收到欧洲药品质量管理局（以下简称"EDQM"） 签发的关于磷酸西格列汀原料药的欧洲药典适用性认证证书（以下简称"CEP 证 书"），现将相关情况公告如下： 一、药品基本情况 药品名称：磷酸西格列汀 药品生产商/持有人：浙江京圣药业有限公司 生产地址：浙江省台州市台州湾经济技术开发区东海第五大道 27 号 证书编号：CEP 2025-109 - Rev 00 发证机构：欧洲药品质量管理局 有效期：自 2025 年 7 月 25 日起五年内 二、药品的其他相关情况 磷酸西格列汀是一种降糖药，能够帮助控制血糖水平，主要用于治疗 2 型糖 尿病。 公司于 2025 年 2 月向 EDQM 递交了磷酸西格列汀原料药的药品注册申请 并获得 CEP 证 ...

Key Points - Zhongsheng Gaoke is planning a change in company control, with a potential transfer of 22.35% of shares at a valuation of 2.5 billion yuan, leading to a stock suspension starting July 16, 2025 [3][4] - Yanshan Technology's subsidiary is participating in a partnership to invest 41.64 million yuan in a fund that will ultimately invest in Bytedance Ltd [5] - Sanyuan Bio received an initial ruling of a 450.64% anti-dumping duty from the US Department of Commerce on erythritol, prompting a shift in sales strategy towards domestic markets [6] - Chutianlong is exploring digital currency projects but faces risks related to new technology development and commercial application [7] - Bertley is establishing a partnership to invest in humanoid robots and other emerging sectors, committing 198 million yuan [8] - China Merchants Highway's chairman resigned due to reaching retirement age [9] - Tibet Summit's controlling shareholder is under investigation for information disclosure violations, but it will not affect the company's operations [10][11] - ST Weir plans to acquire 51% of Zijiang New Materials for 546 million yuan, entering the lithium battery materials sector [12] - ST Yazhen's stock will be suspended for three days due to abnormal trading fluctuations [13] - Dahua Technology's subsidiary is shifting its listing to the Hong Kong Stock Exchange [14] Performance Forecasts - Zhongji Xuchuang expects a net profit increase of 52.64% to 86.57% for the first half of 2025, driven by strong demand for high-end optical modules [15] - Juchip Technology anticipates a 122.28% increase in net profit for the same period, benefiting from successful AI audio chip promotions [16] - Sitwei forecasts a net profit growth of 140% to 180%, with significant revenue increases from smartphone collaborations [17] - Tianyu Co. expects a net profit increase of 144.29% to 238.25%, aided by improved product structure and market strategies [18] - Jinli Yongci predicts a net profit growth of 151% to 180%, focusing on renewable energy and related sectors [19] - Blue Ocean Huaten expects a net profit increase of 152.76% to 190.68%, driven by growth in the new energy heavy truck market [20] - Maiqu'er anticipates a turnaround with a net profit of 1.4 million to 2 million yuan, compared to a loss in the previous year [21] - China Galaxy expects a net profit increase of 45% to 55%, with growth across various business segments [23] - Baicheng Pharmaceutical forecasts a significant decline in net profit, down 95.53% to 100% [24] Major Contracts - Jincheng signed a contract worth approximately 52.98 million USD for underground mining operations in the Democratic Republic of Congo [25] - ST Yundong entered a strategic cooperation agreement for drone development and investment with two companies [26] - Changgao Electric New's subsidiary won contracts totaling 445 million yuan from the State Grid [27] Shareholding Changes - Angli Education plans to reduce its repurchased shares by up to 573.1 million shares [28][29] - Lingzhi Software's shareholders plan to collectively reduce their holdings by up to 2.11% [30] - Founder Technology's major shareholder intends to reduce its stake by up to 2.27% [31] - Zhongfu Shenying's shareholder plans to reduce its stake by up to 1% [32] - Hangzhou Bank's shareholder intends to reduce its stake by up to 0.7% [33] - Haoyun Technology's chairman plans to reduce his stake by up to 400,000 shares [34] Financing Activities - Yuanwang Valley plans to raise up to 300 million yuan through a private placement for RFID production line projects and working capital [35]

Suspension - Sinochem International plans to issue shares to acquire 100% equity of Nantong Xingchen, resulting in stock suspension [1] - Zhongsheng High-Tech is planning a change in company control, leading to stock suspension [2] Private Placement - Yuanwanggu plans to raise no more than 300 million yuan through private placement for the construction of RFID electronic tag production line, Xi'an Innovation Industrial Center, RFID electronic tag chip process upgrade, and to supplement working capital [3] Share Buyback and Increase - Ciwen Media has repurchased 31,700 shares of the company for the first time [4] - Qianyuan Power's controlling shareholder has increased its stake by 0.85% [5] External Investment and Daily Operations - Yanshan Technology's wholly-owned subsidiary Hainan Ruihong is jointly investing in Jiaxing Lanjing with Guoce Investment and others, with the fund directed towards Bytedance Ltd [6] - Bafang Co. plans to cancel 50,000 shares [7] - Bertley intends to invest 198 million yuan in a partnership enterprise, primarily for investing in high-growth unlisted companies in the humanoid robot sector [7] Performance Changes - Juxin Technology expects a net profit of 91 million yuan for the first half of the year, a year-on-year increase of 122.28%, driven by AI technology and increased market demand [8] - Jinli Permanent Magnet anticipates a net profit of 230 million to 265 million yuan, a year-on-year growth of 151% to 180%, focusing on electric vehicles and collaborating with international tech companies [8] - Tianyu Co. expects a net profit of 121 million to 171 million yuan, a year-on-year increase of 144.29% to 238.25%, through optimized product structure and cost control [8] - Guangku Technology forecasts a net profit of 48.56 million to 54.63 million yuan, a year-on-year growth of 60% to 80%, due to technological innovation and new product launches [8] - Sitwei anticipates a net profit of 360 million to 420 million yuan, a year-on-year increase of 140% to 180%, with deepened cooperation in the smartphone sector [8] - Daoshi Technology expects a net profit of 220 million to 238 million yuan, a year-on-year increase of 98.77% to 115.03%, with expanded overseas business and increased production capacity [8] - China Galaxy anticipates a net profit of 6.362 billion to 6.801 billion yuan for the first half of the year, a year-on-year increase of 45% to 55%, with growth in investment trading and wealth management [9] - Haineng Industrial expects a net profit of 64 million to 74 million yuan, a year-on-year increase of 92% to 122%, driven by recovering demand in the consumer electronics market [9] - Zhongji Xuchuang forecasts a net profit of 3.6 billion to 4.4 billion yuan, a year-on-year increase of 52.64% to 86.57%, due to strong capital expenditure and sales growth in high-end optical modules [9]

7月15日晚间，沪深两市多家上市公司发布公告，以下是第一财经对一些重要公告的汇总，供投资者参 考。 【品大事】 中晟高科：筹划公司控制权变更事项 股票明起停牌 中晟高科(002778)公告，公司收到控股股东苏州市吴中金融控股集团有限公司及其一致行动人苏州吴中 区天凯汇达股权投资合伙企业（有限合伙）（以下简称"天凯汇达"）的通知，天凯汇达正在筹划拟以上 市公司市值25亿的价格对外转让其所持公司22.35%股份事宜，该事项可能导致公司控制权发生变更。 本次交易对手方为福州千景投资有限公司，系其实际控制人翁声锦与何从夫妇主要从事投资业务的平台 公司。公司股票自2025年7月16日开市起停牌，预计停牌时间不超过2个交易日。 岩山科技：全资子公司参与设立合伙企业 将以股权形式最终投向Bytedance Ltd. 岩山科技(002195)公告，全资子公司海南瑞弘于近日与上海国策投资管理有限公司、上海子璟商务信息 管理中心、上海起铭信息科技有限公司共同参与投资嘉兴澜晟创业投资合伙企业（有限合伙），并签署 了《嘉兴澜晟创业投资合伙企业（有限合伙）合伙协议》。合伙企业的认缴出资总额为4164万元，公司 全资子公司海南瑞弘作为有 ...

卫星化学：上半年净利润预增31.32%-53.20% 7月15日晚，卫星化学（002648）发布2025年半年度业绩预告，公司预计上半年实现归属于上市公司股 东的净利润27亿元至31.5亿元，同比增长31.32%-53.20%；预计实现扣除非经常性损益后的净利润28.52 亿元至33.02亿元，同比增长27.65%-47.79%。 资料显示，卫星化学成立于2005年8月，主营业务是(聚)丙烯、丙烯酸及酯、乙二醇、环氧乙烷、环氧 丙烷和聚乙烯等产品的生产和销售。 所属行业：基础化工–化学原料–其他化学原料 中国核建：累计新签合同871.49亿元 7月15日晚，中国核建（601611）发布公告称，截至2025年6月，公司累计实现新签合同871.49亿元，累 计实现营业收入531.84亿元。 资料显示，中国核建成立于2010年12月，主营业务是核电工程建设及工业与民用工程建设。 所属行业：建筑装饰–基础建设–基建市政工程 资料显示，怡球资源成立于2001年3月，主营业务是利用所回收的各种废旧铝资源，进行分选、加工、 熔炼等工序，生产出再生铝合金产品。 所属行业：有色金属–工业金属–铝 光库科技：上半年净利润预增60 ...